Etanercept – TNF receptor and IgG1 Fc fusion protein: is it different from other TNF blockers?

By Marotte Hubert   Cimaz Rolando  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 569-572

Informa Healthcare

Access to resources Recommend Favorite

Isolation and characterization of IgG1 with asymmetrical Fc glycosylation

By Ha Sha   Ou Yangsi   Vlasak Josef   Li Yuan   Wang Shiyi   Vo Kim   Du Yi   Mach Anna   Fang Yulin   Zhang Ningyan  

Glycobiology, Vol. 21, Iss. 8, 2011-08 ,pp. : 1087-1096

Oxford University Press

Access to resources Recommend Favorite

In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure

By Wright Ann   Sato Yuji   Okada Toyohiro   Chang Kern Hee   Endo Tamao   Morrison Sherie  

Glycobiology, Vol. 10, Iss. 12, 2000-11 ,pp. : 1347-1355

Oxford University Press

Access to resources Recommend Favorite

Pentameric and Decameric Structures in Solution of Serum Amyloid P Component by X-ray and Neutron Scattering and Molecular Modelling Analyses

By Ashton A.W.   Boehm M.K.   Gallimore J.R.   Pepys M.B.   Perkins S.J.  

Journal of Molecular Biology, Vol. 272, Iss. 3, 1997-09 ,pp. : 408-422

Academic Press

Access to resources Recommend Favorite

Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types

By Kanda Yutaka   Yamada Tsuyoshi   Mori Katsuhiro   Okazaki Akira   Inoue Miho   Kitajima-Miyama Kazuko   Kuni-Kamochi Reiko   Nakano Ryosuke   Yano Keiichi   Kakita Shingo   Shitara Kenya   Satoh Mitsuo  

Glycobiology, Vol. 17, Iss. 1, 2007-01 ,pp. : 104-118

Oxford University Press

Access to resources Recommend Favorite